Bg pattern

FERPLEX 40 mg ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FERPLEX 40 mg ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

FERPLEX 40 mg ORAL SOLUTION

Iron Proteinsuccinylate

Read the entire package leaflet carefully before starting to take the medicine.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, consult your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet.

Contents of the package leaflet:

1- What FERPLEX 40 mg oral solution is and what it is used for

  1. Before taking FERPLEX 40 mg oral solution.

3. How to take FERPLEX 40 mg oral solution.

  1. Possible side effects.
  2. Storage of FERPLEX 40 mg oral solution.
  3. Additional information.

1. What FERPLEX 40 mg oral solution is and what it is used for

FERPLEX 40 mg oral solution is a medicine that provides iron to red blood cells, treating iron deficiency states and curing anemia (reduction of hemoglobin levels and the number and size of red blood cells) due to this iron deficiency.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. BEFORE TAKING FERPLEX 40 mg oral solution

Do not take FERPLEX 40 mg oral solution

  • If you are allergic (hypersensitive) to Iron Proteinsuccinylate or any of the other components of FERPLEX 40.
  • If you are allergic to milk proteins.
  • If you have a disease that causes iron accumulation in the body (hemochromatosis, hemosiderosis).
  • If you have pancreatitis (inflammation of the pancreas) or liver cirrhosis (a chronic liver disease characterized by the formation of fibrosis or "scars" in liver tissue that alter its structure and normal function) due to iron accumulation
  • If you have anemia due to causes other than iron deficiency.

Be careful with FERPLEX 40 mg oral solution:

  • Before starting treatment with this medicine, if you have anemia or iron deficiency, consult your doctor.

Use of other medicines

Tell your doctor or pharmacist if you are using, or have recently used, other medicines, including those obtained without a prescription.

FERPLEX 40 mg oral solution may reduce the intestinal absorption and therefore the effect of some medicines, such as:

  • Antibiotics, such as quinolones and tetracyclines.
  • Bisphosphonates, used in patients with osteoporosis (bone loss and weakening).
  • Penicillamine, used for arthritis (joint inflammation).
  • Alpha-methyldopa, used to treat high blood pressure.
  • Thyroxine, used to treat hypothyroidism (underactive thyroid gland).
  • Levodopa and carbidopa, used to treat Parkinson's disease
  • Myphenolate mofetil, used to prevent transplant rejection

The intestinal absorption of iron and therefore the efficacy of FERPLEX 40 mg oral solution may be reduced if taken with the following medicines, so it is recommended to wait at least 2 hours between taking any of these medicines and taking FERPLEX:

  • antacids, normally used in patients with gastric acidity
  • chloramphenicol (antibiotic)
  • cholestyramine, used in patients with high cholesterol
  • medicines for the treatment of stomach ulcers or esophageal reflux such as omeprazole, lansoprazole, pantoprazole

Interference with diagnostic tests:

This medicine may interfere with laboratory tests for the investigation of occult blood in stool.

Taking FERPLEX 40 mg oral solution with food and drinks:

Some plant-based foods, milk, coffee, and tea reduce iron absorption, so it is recommended not to take FERPLEX during the two hours following consumption of any of these foods.

The simultaneous ingestion of freshly squeezed citrus juices (orange, lemon, etc.) may enhance the absorption of iron derivatives.

Pregnancy and breastfeeding:

Consult your doctor or pharmacist before using any medicine.

FERPLEX 40 mg oral solution is particularly indicated in iron deficiency states that occur during pregnancy and breastfeeding, so no special precautions are necessary.

Driving and using machines:

No effects have been observed on the ability to drive and use machines.

Important information about some of the components of FERPLEX 40 mg oral solution:

This medicine contains 1400 mg of sorbitol per vial.

Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine. Sorbitol may cause gastrointestinal upset and a mild laxative effect

This medicine contains 61.1 mg of propylene glycol in each vial, equivalent to 4.1 mg/ml. If the baby is less than 4 weeks old, consult your doctor or pharmacist, especially if the baby has been given other medicines that contain propylene glycol or alcohol

This medicine contains 38.4 mg of sodium (main component of table salt/cooking salt) in each vial. This is equivalent to 1.9% of the maximum daily sodium intake recommended for an adult.

FERPLEX may cause allergic reactions (possibly delayed) because it contains propyl hydroxybenzoate sodium salt (E-217) and methyl hydroxybenzoate sodium salt (E-219).

3. How to take FERPLEX 40 mg oral solution

Follow the administration instructions of FERPLEX indicated by your doctor. Consult your doctor or pharmacist if you have any doubts. Remember to take your medicine.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Your doctor will indicate the duration of your treatment. Do not stop treatment before, as the desired effect will not be achieved.

Take this medicine preferably a few hours before meals

The contents of the vial can be taken directly or diluted with water.

The normal doses are as follows:

Adults: 1-2 vials per day, according to medical criteria, (equivalent to 40-80 mg of iron) divided into 2 doses

Children: Administer 1.5 ml of solution/Kg/day (equivalent to 4 mg of iron) or according to medical criteria, divided into 2 doses.

The duration of treatment depends on the nature and severity of the iron deficiency. Treatment should continue until iron reserves are replenished.

If you think the action of FERPLEX is too strong or too weak, tell your doctor or pharmacist.

If you take more FERPLEX 40 mg oral solution than you should:

If you take more FERPLEX than you should, consult your doctor or pharmacist immediately or call the Toxicology Information Service: Telephone 91 562 04 20.

If you forget to take FERPLEX 40 mg oral solution

Do not take a double dose to make up for forgotten doses. If you forget to take a dose, take the next one as soon as possible and continue as before.

If you have any further questions about the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, FERPLEX 40 mg oral solution can cause side effects, although not everyone gets them

The following side effects have been reported (frequency unknown):

Gastrointestinal disorders:stomach pain, nausea, constipation or diarrhea, which usually disappear quickly after reducing the dose or, if necessary, after stopping treatment.

Disorders of the skin and subcutaneous tissue:allergic reactions.

Appearance of green or black stools, due to iron elimination. This side effect is harmless.

If you think any of the side effects you are suffering from is serious, or if you notice any side effects not mentioned in this package leaflet, tell your doctor or pharmacist.

5. Storage of FERPLEX 40 mg oral solution

Do not store above 30°C

Keep out of the reach and sight of children.

Do not use FERPLEX 40 after the expiration date stated on the packaging. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. ADDITIONAL INFORMATION

Composition of FERPLEX 40 mg oral solution:

The active ingredient is Iron Proteinsuccinylate (contains milk protein). Each 15 ml vial of oral solution contains 800 mg of iron proteinsuccinylate, equivalent to 40 mg of iron. The other components are: sorbitol (E-420), propylene glycol, propyl hydroxybenzoate sodium salt (E-217), methyl hydroxybenzoate sodium salt (E-219), sodium saccharin, blackcurrant flavor, sodium hydroxide, and purified water.

Appearance of the product and packaging content

Ferplex 40 mg is presented as a transparent oral solution, brown in color and with a characteristic odor.

Each package contains 20 vials.

Marketing authorization holder

ITALFARMACO S.A.

San Rafael, 3

28108 Alcobendas (Madrid)

Telephone: +34 91 657 23 23

Fax: +34 91 657 23 61

Manufacturer:

ITALFARMACO S.A.

San Rafael, 3

28108 Alcobendas (Madrid)

LACER, S.A.

Boters, 5, 08290 Cerdanyola del Vallès-Barcelona-Spain

This package leaflet was approved in March 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for FERPLEX 40 mg ORAL SOLUTION

Discuss questions about FERPLEX 40 mg ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for FERPLEX 40 mg ORAL SOLUTION?
FERPLEX 40 mg ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FERPLEX 40 mg ORAL SOLUTION?
The active ingredient in FERPLEX 40 mg ORAL SOLUTION is ferric proteinsuccinylate. This information helps identify medicines with the same composition but different brand names.
How much does FERPLEX 40 mg ORAL SOLUTION cost in pharmacies?
The average pharmacy price for FERPLEX 40 mg ORAL SOLUTION is around 12.52 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures FERPLEX 40 mg ORAL SOLUTION?
FERPLEX 40 mg ORAL SOLUTION is manufactured by Italfarmaco S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FERPLEX 40 mg ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FERPLEX 40 mg ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FERPLEX 40 mg ORAL SOLUTION?
Other medicines with the same active substance (ferric proteinsuccinylate) include FERROCUR 40 mg ORAL SOLUTION, LACTOFERRIN 40 mg ORAL SOLUTION, FERACCRU 30 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media